[Role of Cdk5 in dopamine signaling and addiction].
Nishi
Akinori
A
nishia@med.kurume-u.ac.jp
D000818:Animals; D003342:Corpus Striatum / Q000201:enzymology; D017868:Cyclic AMP-Dependent Protein Kinases / Q000502:physiology; D051360:Cyclin-Dependent Kinase 5 / Q000502:physiology*; D003712:Dendrites / Q000502:physiology; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32 / Q000378:metabolism; D006801:Humans; D010766:Phosphorylation; D016760:Proto-Oncogene Proteins c-fos / Q000502:physiology; D017447:Receptors, Dopamine D1 / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics* / Q000502:physiology*; D019966:Substance-Related Disorders / Q000235:genetics*; D014446:Tyrosine 3-Monooxygenase / Q000502:physiology; D051300:Wiskott-Aldrich Syndrome Protein Family / Q000502:physiology
D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; C064269:FOSB protein, human; C497928:PPP1R1B protein, human; D016760:Proto-Oncogene Proteins c-fos; D017447:Receptors, Dopamine D1; C114864:WASF1 protein, human; D051300:Wiskott-Aldrich Syndrome Protein Family; D014446:Tyrosine 3-Monooxygenase; D051360:Cyclin-Dependent Kinase 5; D017868:Cyclic AMP-Dependent Protein Kinases; D004298:Dopamine